2020 ASCO Virtual Direct™ Highlights

 

Avatar

2020 ASCO Update on Platinum Sensitive, Relapsed Ovarian Cancer: Is There an OS Benefit With Maintenance PARPi?

By Total Health 1244 Videos FEATURING Carolyn Muller
348 views
October 13, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

05:15
Lilly Medical Affairs

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo

Featured Video

03:15
Lilly Medical Affairs

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh
GYN
19:19

2020 ASCO Update on Recurrent Ovarian Cancer: Does Secondary Cytored…

Total Health

C. Muller

24 views
07:40

2020 ASCO Update on Platinum Sensitive, Relapsed Ovarian Cancer: Is …

Total Health

C. Muller

348 views
09:08

PARPi Efficacy in Recurrent Platinum Sensitive Ovarian Cancer: Is Ol…

Total Health

C. Muller

128 views